Guidelines for the use of antiretroviral agents in pediatric HIV infection. Centers for Disease Control and Prevention. Department of Health and Human Services. Health Resources and Services Administration. National Institutes of Health. NGC:008663

Publication Details

Author(s):

• AHRQ (US) - Agency for Healthcare Research and Quality

Country(ies) of application:

• United States

Language(s):

• English

Type of Publication:

Guideline Clearing Report

Primary Contact:

Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov

Publication URL:

Open Publication URL in a new window

Publication Scope:

• Assessment/diagnosis
• Management
• Prevention
• Screening

Publication Status:

Published

Date of publication:

Aug 11, 2011

Due for Review:

-

Diseases / Conditions Addressed

MeSH Terms addressed:

• Sexually Transmitted Diseases (C01.539.780 / C02.800)
  • Sexually Transmitted Diseases, Viral (C02.800.801)
    • HIV Infections (C02.800.801.400)
• Immune System Disorders / Immunologic Diseases (C20)
  • Immunologic Deficiency Syndromes (C20.673)
    • HIV Infections (C20.673.480)
• Therapeutics (E02)
  • Drug Therapy (E02.319)
    • Antiretroviral Therapy (E02.319.310.075)
• Pharmacologic Actions (D27.505)
  • Anti-Retroviral Agents (D27.505.954.122.388.077)
• Virus Infections (C02)
  • RNA Virus Infections (C02.782)
    • HIV Infections (C02.782.815.616.400)
• Pediatrics (G02.403.776.610)

Guideline key questions